Osteoarthritis, Knee Clinical Trial
Official title:
The Relative Effectiveness of Three Full Kinetic Chain Treatment Protocols for Osteoarthritis of the Knee: Manual Therapy, Rehabilitation and a Combination Thereof
Common medical therapies for knee osteoarthritis are patient education, drug and physical therapy, exercise and surgery. These modalities may offer improvement but drugs and surgery carry significant risk. Manipulative therapy for KOA gives pain relief and increased function. However, research suggests addition of manipulative and soft tissue therapy (to the entire kinetic chain: lumbosacral, sacroiliac, hip, knee, ankle and foot joints), may give a better outcome. Exercise therapy is considered an effective and standard care for KOA.
Patients seek treatment from chiropractors for osteoarthritis (OA) and Knee OA (KOA).
Significant KOA impacts 10 % of individuals aged ≥63 particularly with radiographic changes;
and by age 65, 80% have these x-ray changes. KOA may be the largest cause of decreased
mobility, function, disability and pain in people aged ≥ 50 in the US. KOA causes 30% > age
60 to experience decreased social activities of daily living, increased cardiovascular risk,
increased fall risk and secondary depression. Overall KOA prevalence is 4% in young adults,
85% in those > 75. Beyond great personal suffering - in the US, annual financial costs
associated with OA were $60 billion per year in 2000 and, for all OA and rheumatic disease
$128 billion in 2003. Estimates in 2005 were 27 million people suffer significantly due to
OA and by 2020 in the US and other developed nations > 12 million will suffer serious, and
19 million minor to moderate work or activity related disability from OA and KOA, with the
highest prevalence expected in women.
Medical care commonly prescribed for KOA is lifestyle accommodation (decreased activity, a
cane, high chairs and toilet seats, etc), non-steroidal anti-inflammatory drugs (NSAIDS),
anti-arthritics, steroids, various and sundry prescription and non-prescription oral and
topical medications and exercise. Randomized controlled trials (RCTS) support exercise for
KOA treatment, proven superior to placebo. At least 50% (and periodically up to 90 percent)
of KOA patients regularly use NSAIDs. Frequent minor but intermittently serious
gastrointestinal and cardiovascular adverse reactions to chronic use of NSAIDS occur, and
there is evidence that using exercise/rehabilitation with or without manipulative (MAN)
therapy may give safer, similar or equivalent relief. Supported by earlier RCTs, MAN therapy
with and without soft tissue and exercise therapy for KOA appears superior to placebo and
equal or superior to exercise. Although Chiropractic has conducted and published two RCTs of
manipulative therapy for KOA, the profession has not yet conducted an RCT with combined full
kinetic chain MAN therapy, soft tissue and rehabilitation versus standard care
(rehabilitation or exercise therapy) nor studied optimum dose for various patients. 1). in
effect only 1 study of such combined care (MAN therapy, soft tissue and rehabilitation or
exercise therapy) exists; 2) more studies of MAN therapy combined with rehabilitation are
needed to establish: a). equivalent or b). superior treatment efficacy with full kinetic
chain therapy and to c). use 'dose time to response' techniques to study the optimum number
of treatments for various patients and (to help determine who will respond and will not
respond and why) and d)collect data to develop future cost effective research.
Significant morbidity and occasional mortality from NSAID and drug-related complications and
surgery; difficulty in obtaining compliance with prolonged exercise protocols; apparent
similar, equivalent or superior outcomes (manipulative therapy with and without, but
possibly superior with, combined rehabilitation) in pain relief, mobility and function; the
possibility of decreasing falls with their appalling sequela in morbidity, mortality and
expense; justifies further research into multimodal manipulative therapy for treatment of
KOA. Data suggests such full kinetic chain MAN therapy with rehabilitation may give earlier,
effective, less costly outcomes and reflects a common clinical chiropractic approach to KOA.
In addition to the knee joint, KOA disability has been demonstrated to be significantly
worsened by hip joint dysfunction, for example restricted hip flexion increases KOA pain and
dysfunction; and there are similar associations throughout the full kinetic chain for
example lumbosacral spine joint dysfunction may increase knee pain and dysfunction.
Manipulative therapy applied appropriately to the full, kinetic chain (to the full axial and
appendicular skeleton -the spine and extremities) combined with rehabilitation may be a
superior treatment for knee OA.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03895489 -
Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses
|
N/A | |
| Completed |
NCT03660943 -
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
|
Phase 3 | |
| Completed |
NCT04531969 -
Comparison of Outpatient and Inpatient Spa Therapy
|
N/A | |
| Completed |
NCT02848027 -
Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment
|
Phase 3 | |
| Completed |
NCT05160246 -
The Instant Effect of Kinesiology Taping in Patients With Knee OA
|
N/A | |
| Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
| Completed |
NCT03643588 -
The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain
|
N/A | |
| Active, not recruiting |
NCT05100225 -
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
|
Phase 2 | |
| Active, not recruiting |
NCT04061733 -
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
|
N/A | |
| Completed |
NCT04051489 -
A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
|
||
| Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
| Recruiting |
NCT05447767 -
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg
|
Phase 2 | |
| Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
| Not yet recruiting |
NCT03225911 -
Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis
|
N/A | |
| Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
| Completed |
NCT05703087 -
Positive Cueing in Knee Arthroplasty.
|
N/A | |
| Not yet recruiting |
NCT06042426 -
Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population
|
Phase 4 | |
| Completed |
NCT03037489 -
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
|
Phase 2 | |
| Completed |
NCT02901964 -
Effect of Strengthening the Hip Abductor in Patients With Knee Osteoarthritis: Randomized Controlled Trial
|
N/A | |
| Terminated |
NCT02615522 -
Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
|